Diasorin SpA buy melinda
Start price
07.04.19
/
50%
€91.15
Target price
16.05.19
€96.00
Performance (%)
7.02%
End price
16.05.19
€97.55
Summary
This prediction ended on 16.05.19 with a price of €97.55. With a performance of 7.02%, the BUY prediction by melinda for Diasorin SpA closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Diasorin SpA | 6.943% | 6.943% | -6.604% | -26.405% |
| iShares Core DAX® | 4.094% | 4.888% | 17.421% | 22.413% |
| iShares Nasdaq 100 | 1.424% | -0.445% | 37.618% | 58.203% |
| iShares Nikkei 225® | -1.572% | -4.911% | 12.951% | 7.961% |
| iShares S&P 500 | 1.822% | 0.776% | 29.182% | 49.914% |
According to melinda what are the pros and cons of Diasorin SpA for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Diasorin SpA diskutieren
Secteur Equipement, fournitures et distribution médicale Agenda 24/04 Assemblée générale
DiaSorin est spécialisé dans le développement, la fabrication et la commercialisation de réactifs de diagnostic in vitro. Les produits utilisent le traitement des maladies infectieuses et virales, des pathologies thyroïdiennes, des cancers, etc.
A fin 2017, le groupe dispose de 7 sites de production d'implants à Italie, aux Etats-Unis (2), en Allemagne, au Royaume Uni, en Irlande et en Afrique du Sud.
La répartition géographique du CA est la suivante: Italie (22,2%), Europe (27,1%), Amérique du Nord (32%) et autres (18,7%).
Stopped prediction by melinda for Diasorin SpA
Diasorin SpA
Start price
Target price
Perf. (%)
€142.25
06.06.21
06.06.21
-
06.06.22
06.06.22
-15.04%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
Diasorin SpA
Start price
Target price
Perf. (%)
€80.80
12.10.18
12.10.18
€93.70
21.01.19
21.01.19
-1.92%
21.01.19
21.01.19
Could be worthwhile Investment >10% per year